IITRI NEWS

NEWS

We are ready to answer your questions and provide guidance.

News

Service Spotlight: Exposure Atmosphere Characterization

Service Spotlight: Exposure Atmosphere Characterization

STARTING OFF ON THE RIGHT FOOT Our inhalation services include preliminary method development activities as the necessary first step for inhalation toxicology studies. The selection and characterization of the test atmosphere to be realistic and extensively measured...

SARS-CoV-2 Variants of Concern Now Available

SARS-CoV-2 Variants of Concern Now Available

IITRI now has access to multiple SARS-CoV-2 variants. Currently available: B.1.1.7 (Alpha), B.1.351 (Beta), P.1 (Gamma). Available soon: B.1.617.1 (Kappa) and B.1.617.2 (Delta) These variants are available for use in our assays (immunostain and neutralization) as well...

Immunostain SARS-CoV-2 Efficacy Assay Available

Immunostain SARS-CoV-2 Efficacy Assay Available

IITRI now offers an improved efficacy assay for looking at effects of drugs on SARS-CoV-2. Although this assay no longer includes a cytotoxicity readout, we offer a neutral red assay in BSl-2 instead if needed. This current assay uses immunostaining and provides more...

IITRI has developed a new bleomycin mouse model

IITRI has developed a new bleomycin mouse model

IITRI now offers an improved bleomycin (BLM) induced pulmonary fibrosis mouse model that can recapitulate many of the complex profibrotic responses that are also observed in the lungs of those suffering from idiopathic pulmonary fibrosis (IPF) and perhaps COVID-19...